Table 3.
Baseline (pre rACLR) Patient-Reported Outcome Scores
| Median (25%, 75% quartile) Baseline Patient Reported Outcome Scores | Overall (n=1234) | No Bone Grafting (n=1075) | 1-Stage Bone Grafting (n=64) | 2-Stage Bone Grafting (n=95) | P value |
|---|---|---|---|---|---|
|
| |||||
| IKDC | 52 (38, 63) | 52 (39, 64) | 51 (39, 60) | 48 (34, 59) | 0.22 |
| KOOS | |||||
| • Symptoms | 68 (54, 82) | 68 (54, 82) | 71 (50, 82) | 68 (54, 82) | 0.95 |
| • Pain | 75 (58, 86) | 75 (58, 86) | 75 (60, 86) | 72 (61, 86) | 0.87 |
| • Activities of Daily Living (ADL) | 87 (69, 96) | 87 (69, 96) | 86 (66, 96) | 85 (63, 94) | 0.66 |
| • Sports/recreation | 45 (25, 65) | 45 (25, 65) | 40 (15, 65) | 40 (20, 59) | 0.21 |
| • Quality of life (QOL) | 31 (19, 44) | 31 (19, 44) | 31 (13, 45) | 25 (13, 38) | 0.001 1 |
| WOMAC | |||||
| • Stiffness | 75 (50, 88) | 75 (50, 88) | 75 (59, 88) | 75 (50, 88) | 0.43 |
| • Pain | 85 (70, 95) | 85 (70, 95) | 80 (65, 95) | 80 (65, 94) | 0.48 |
| • Activities of Daily Living (ADL) | 87 (69, 96) | 87 (69, 96) | 86 (66, 96) | 85 (63, 94) | 0.64 |
| Marx Activity Level | 11 (4, 16) | 12 (4, 16) | 7 (3, 15) | 6 (0, 12) | <0.001 2 |
Key:
ANOVA tests showed a significant difference in this variable between groups (p=0.001). Tukey HSD multiple comparison test showed that the 2-staged bone grafting group was significantly lower than the no bone grafting group (p=0.001). The 2-staged bone grafting group was not significantly lower than the 1-stage bone grafting group (p=0.20).
ANOVA tests showed a significant difference in this variable between groups (p<0.001). Tukey HSD multiple comparison test showed that the 2-staged bone grafting group was significantly lower than the no bone grafting group (p<0.001). The 1-stage bone grafting group was not significantly different than the 2-staged bone grafting group (p=0.29) or the no bone grafting group (p=0.07).